胰岛素样生长因子II mRNA结合蛋白3在中枢神经系统的原发性扩散性大B细胞淋巴瘤中高度表达
Kentaro Odani1, Masakazu Fujimoto2, Hirotake Fujii1
1Department of Diagnostic Pathology, Osaka Red Cross Hospital, Osaka, Japan.
Journal of clinical and experimental hematopathology : JCEH
|September 29, 2024
概括
胰岛素样生长因子II mRNA结合蛋白3 (IMP3) 免疫组织化学在中枢神经系统扩散型大B细胞淋巴瘤 (CNS-DLBCL) 中表达高. IMP3可能有助于诊断中枢神经系统-DLBCL,特别是当瘤细胞稀缺时.
科学领域:
- 神经病理学神经病理学
- 在瘤学瘤学.
- 免疫组织化学 免疫组织化学
背景情况:
- 主要的中枢神经系统扩散性大B细胞淋巴瘤 (CNS-DLBCL) 诊断是具有挑战性的,因为有限的活检组织.
- 准确的诊断对于有效治疗中枢神经系统-DLBCL至关重要.
研究的目的:
- 评估胰岛素样生长因子II mRNA结合蛋白3 (IMP3) 免疫组织化学 (IHC) 作为中枢神经系统DLBCL的辅助诊断标记物的实用性.
- 评估与其他DLBCL亚型和炎症性脑疾病相比,中枢神经系统DLBCL中的IMP3表达.
主要方法:
- 在57个中枢神经系统-DLBCL活检样本,68个非中枢神经系统-DLBCL样本和12个炎症性脑疾病样本上进行了IMP3免疫组织化学 (IHC).
- 细胞质IMP3表达被量化为阳性瘤细胞的百分比.
主要成果:
- 百分之百的中枢神经系统-DLBCL病例 (57/57) 在≥50%的瘤细胞中显示出细胞质IMP3表达.
- 在88.2% (60/68) 的非CNS-DLBCL中观察到IMP3表达.
- 在炎症性脑疾病中没有发现IMP3阳性B细胞 (P < 0.0001).
结论:
- 在中枢神经系统DLBCL中IMP3的表达很高,但在其他DLBCL类型中也很高,这表明特异性有限.
- IMP3 IHC可以是一个有价值的辅助工具,用于区分中枢神经系统DLBCL和反应性病变,特别是当瘤细胞稀疏或变形时.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


